Open AccessSubstitute estrogen therapy at post-varicotomy
Author(s) -
I. T. Riabtseva,
К. А. Шаповалова
Publication year - 2002
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd90020
Subject(s) - medicine , estrogen , urology , endocrinology , body mass index , estrogen therapy
The efficiency of preparation Divigel was specified in this work (1 mg of estradiol hemihydrate) within 12 months of use in women with post-varicotomy syndrome. After 6 months all patients-women have demonstrated the trust reduction Cuperman index, FSG level in blood serum and E2 concentration increase. After 6 months the osseous lost inhibition was noted, after 12 months the osseous mass increase was detected.Divigel therapy tells on positively on blood atherogenic profile.